Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yao An Lee

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Heterogeneous Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Acute Kidney Injury: A Causal Learning ApproachHao Dai, Yao An Lee, Jiang Bian, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
High-Throughput Safety Signal Detection for Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 DiabetesHao Dai, Yao An Lee, Jiang Bian, et al.
Studies in Health Technology and Informatics|August 8, 2025
Transforming the Medicare Claims Data to the OMOP Common Data ModelYao An Lee, Ying Lu, Jiang Bian, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Harmonizing Medicare Claims Data with OMOP: A Validated ETL PipelineYao An Lee, Ying Lu, Jiang Bian, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Develop and Validate A Fair Machine Learning Model to Indentify Patients with High Care-Continuity in Electronic Health Records DataYao An Lee, Tiange Tang, Yu Huang, et al.
Diabetes, Obesity & Metabolism|June 5, 2026
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients With Obesity and Without Type 2 DiabetesPareeta Kotecha, Yao An Lee, Michael F Presti, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Characterize Disease Progression Subphenotypes in Real World Populations with Overweight and Obesity using a Graph-based Neural Network FrameworkYao An Lee, Yu Huang, Hao Dai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Glycated hemoglobin and body mass index as mediators of GLP-1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetesHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
JAMA Neurology|April 7, 2025
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related DementiasHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2025
Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulationHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Heterogeneous Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Acute Kidney Injury: A Causal Learning ApproachHao Dai, Yao An Lee, Jiang Bian, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
High-Throughput Safety Signal Detection for Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 DiabetesHao Dai, Yao An Lee, Jiang Bian, et al.
Studies in Health Technology and Informatics|August 8, 2025
Transforming the Medicare Claims Data to the OMOP Common Data ModelYao An Lee, Ying Lu, Jiang Bian, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 23, 2026
Harmonizing Medicare Claims Data with OMOP: A Validated ETL PipelineYao An Lee, Ying Lu, Jiang Bian, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Develop and Validate A Fair Machine Learning Model to Indentify Patients with High Care-Continuity in Electronic Health Records DataYao An Lee, Tiange Tang, Yu Huang, et al.
Diabetes, Obesity & Metabolism|June 5, 2026
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients With Obesity and Without Type 2 DiabetesPareeta Kotecha, Yao An Lee, Michael F Presti, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Characterize Disease Progression Subphenotypes in Real World Populations with Overweight and Obesity using a Graph-based Neural Network FrameworkYao An Lee, Yu Huang, Hao Dai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Glycated hemoglobin and body mass index as mediators of GLP-1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetesHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
JAMA Neurology|April 7, 2025
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related DementiasHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2025
Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulationHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
Pageof 3